Sort publications on year
-
Pharmaco-Economics
Le coût de l’asthme en France et les implications économiques de son niveau de contôle
GADENNE S, PRIBIL C, CHOUAID C, VERGNENEGRE A, DETOURNAY B
Rev Mal Respir ; 2011;28(4):419-426
-
Pharmaco - Epidemiology
Instauration de l’insulinothérapie chez les diabétiques de type 2 en France : données de l’étude INSTIGATE
CHARLES MA, CHARTIER F, BONNARD C, SMITH H, FAGNANI F, SALAUN-MARTIN C
Médecine des Maladies Métaboliques ; 2011;5(2):189-198
-
Pharmaco - Epidemiology
Five-year extension of a clinical trial comparing the EX-PRESS glaucoma filtration device and trabeculectomy in primary open-angle glaucoma
DE JONG L, LAFUMA A, AGUADE AS, BERDEAUX G
Clin Ophtalmol ; 2011;5:527-533
-
Pharmaco - Epidemiology
Epidemiology of atrial fibrillation in France : extrapolation of international epidemiological data to France and analysis of french hospitalization data
CHARLEMAGNE A, BLACHER J, COHEN A, COLLET JP, DIEVART F, DE GROOTE P, HANON O, LEENARDT A, PINEL JF, PISICA-DONOSE G, LE HEUZEY JY
Arch Cardiovasc Dis ; 2011;104:115-124
-
Pharmaco-Economics
Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States
YE X, RUPNOW M, BASTIDE P, LAFUMA A, OVINGTON L, JARVIS WR
Am J Infect Control ; 2011;39(8):647-654
-
Pharmaco - Epidemiology
Do two intravenous iron sucrose preparations have the same efficacy ?
ROTTEMBOURG J, KADRI A, LEONARD E, DANSAERT A, LAFUMA A
2011 - Nephrol Dial Transplant ; 26 - 10 : 3262-3267
-
Pharmaco-Economics
Cost effectivenessof posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for theFrench healthcare system
MICHALLET M, GANGNEUX JP, LAFUMA A, HERBRECHT R, RIBAUD P, CAILLOT D, DUPONT B, MOREAU P, BERGER P, O’SULLIVAN AK
J Med Econ ; 2011;14(1):28-35
-
Pharmaco-Economics
Comparison of outcomes with multifocal intraocular lenses : A meta-analysis
COCHENER B, LAFUMA A, KHOSHNOOD B, COUROUVE L, BERDEAUX G
Clin Ophtalmol ; 2011;5:45-56
-
Pharmaco - Epidemiology
Biomechanical and psychosocial work exposures and musculoskeletal symptoms among vineyard workers
BERNARD C, COUROUVE L, BOUEE S, ADJEMIAN A, CHRETIEN JC, NIEDHAMMER I
J Occup Health ; 2011;53:297-311
-
Pharmaco - Epidemiology
Type 2 diabetes treatment intensification in general practice in France in 2008-2009 : the DIAttitude Study
BALKAU B, BOUEE S, AVIGNON A, VERGES B, CHARTIER I, AMELINEAU E, HALIMI S
Diabetes Metab ; 2012;38:29-35
-
Pharmaco - Epidemiology
Therapeutic management of orally treated type 2 diabetic patients, by French general practitioners in 2010 : the DIAttitude Study
HALIMI S, BALKAU B, ATTALI C, DETOURNAY B, AMELINEAU E, BLICKLE JF
Diabetes Metab ; 2012;38:36-46
-
Pharmaco - Epidemiology
Prise en charge du purpura thrombopénique immunologique en France avant la mise à disposition des agonistes du récepteur à la thrombopoïétine
MICHEL M, DOZ M, LECLERC-TEFFAHI S, DETOURNAY B, LEVY-BACHELOT L
Rev Med Interne ; 2012;33:305–310
-
Pharmaco - Epidemiology
Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007)
BOURLIERE M, OUZAN D, ROSENHEIM M, DOFFOËL M, MARCELLIN P, PAWLOTSKY JM, SALOMON L, FAGNANI F, ROUANET S, PINTA A, VRAY M
SALOMON L, FAGNANI F, ROUANET S, PINTA A, VRAY MAntivir Ther ; 2012;17(1):101-110
-
Pharmaco-Economics
Long term treatment of atrial fibrillation in elderly patients: A decision analysis
LAFUENTE C, EMERY C, LAURENDEAU C, FAGNANI F, BERGMANN JF
Int J Cardiol ; 2012;155(1):102-109
-
Pharmaco-Economics
L’investissement industriel en recherche clinique à l’hôpital : une estimation pour la France en 2010
FAGNANI F
Thérapie ; 2012;67(2):89-96